Prof. Anil Gulati

Showing: 1 - 1 of 1 Articles

Centhaquine Set to Enter US-FDA Approved Phase 3 Clinical Trial in US and Europe: First Ever Indian Drug to get Direct Approval for such a Trial

Pharmazz India Private Limited, a majority-owned subsidiary of Pharmazz, Inc.’s first-in-class drug developed in India, …